Immunotherapy and Pancreatic Cancer: A Lost Challenge?

Autor: Laface C; Medical Oncology, Dario Camberlingo Hospital, 72021 Francavilla Fontana, Italy., Memeo R; Unit of Hepato-Pancreatic-Biliary Surgery, 'F. Miulli' General Regional Hospital, 70021 Acquaviva Delle Fonti, Italy., Maselli FM; Medical Oncology, Dario Camberlingo Hospital, 72021 Francavilla Fontana, Italy., Santoro AN; Medical Oncology, Dario Camberlingo Hospital, 72021 Francavilla Fontana, Italy., Iaia ML; Medical Oncology, Dario Camberlingo Hospital, 72021 Francavilla Fontana, Italy., Ambrogio F; Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, 70124 Bari, Italy., Laterza M; Division of Cardiac Surgery, University of Bari, 70124 Bari, Italy., Cazzato G; Department of Emergency and Organ Transplantation, Pathology Section, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy., Guarini C; Medical Oncology, Dario Camberlingo Hospital, 72021 Francavilla Fontana, Italy., De Santis P; Medical Oncology, Dario Camberlingo Hospital, 72021 Francavilla Fontana, Italy., Perrone M; Medical Oncology, Dario Camberlingo Hospital, 72021 Francavilla Fontana, Italy., Fedele P; Medical Oncology, Dario Camberlingo Hospital, 72021 Francavilla Fontana, Italy.

Publikováno v: Life (Basel, Switzerland) [Life (Basel)] 2023 Jun 30; Vol. 13 (7). Date of Electronic Publication: 2023 Jun 30.

Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?

Autor: Perrone M; Medical Oncology, Dario Camberlingo Hospital, Francavilla Fontana, Puglia, Italy., Giuliani F; Oncology Unit, San Paolo Hospital, Bari, Puglia, Italy., Sanna V; Oncology Unit, Sassari University Hospital, Sassari, Italy., Bruno S; Oncology Unit, San Paolo Hospital, Bari, Puglia, Italy., Melaccio A; Oncology Unit, San Paolo Hospital, Bari, Puglia, Italy., Santoro AN; Medical Oncology, Dario Camberlingo Hospital, Francavilla Fontana, Puglia, Italy., Laface C; Medical Oncology, Dario Camberlingo Hospital, Francavilla Fontana, Puglia, Italy., Maselli FM; Medical Oncology, Dario Camberlingo Hospital, Francavilla Fontana, Puglia, Italy., Iaia ML; Medical Oncology, Dario Camberlingo Hospital, Francavilla Fontana, Puglia, Italy., Guarini C; Medical Oncology, Dario Camberlingo Hospital, Francavilla Fontana, Puglia, Italy., Fancellu A; Department of Medical, Surgical and Experimental Sciences, Unit of General Surgery, Sassari University Hospital, Sassari, Italy., Fedele P; Medical Oncology, Dario Camberlingo Hospital, Francavilla Fontana, Puglia, Italy.

Publikováno v: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2023 Jun; Vol. 24 (8), pp. 887-900. Date of Electronic Publication: 2023 Apr 12.

Reliability of patient-reported toxicities during adjuvant chemotherapy.

Autor: Cremante M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Pastorino A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Ponzano M; Department of Health Sciences (DISSAL), University of Genova, 16132 Genova, Italy., Grassi M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Martelli V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Puccini A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Catalano F; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Murianni V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Iaia ML; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Puglisi S; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Gandini A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Caprioni F; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Andretta V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Pessino A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Comandini D; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Sciallero MS; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Mammoliti S; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy., Sormani MP; Department of Health Sciences (DISSAL), University of Genova, 16132 Genova, Italy., Sobrero A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy. Electronic address: alberto.sobrero@hsanmartino.it.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Mar; Vol. 182, pp. 115-121. Date of Electronic Publication: 2023 Jan 14.

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.

Autor: Puccini A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Ponzano M; Department of Health Sciences (DISSAL), University of Genova, 16132 Genova, Italy., Dalmasso B; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, L.go Rosanna Benzi X, 16132 Genoa, Italy., Vanni I; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy.; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, L.go Rosanna Benzi X, 16132 Genoa, Italy., Gandini A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Puglisi S; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Borea R; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Cremante M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Bruno W; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy.; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, L.go Rosanna Benzi X, 16132 Genoa, Italy., Andreotti V; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, L.go Rosanna Benzi X, 16132 Genoa, Italy., Allavena E; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Martelli V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Catalano F; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Grassi M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Iaia ML; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Pirrone C; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy., Pastorino A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Sciallero S; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Ghiorzo P; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy.; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, L.go Rosanna Benzi X, 16132 Genoa, Italy., Pastorino L; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, V.le Benedetto XV 6, 16132 Genoa, Italy.; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, L.go Rosanna Benzi X, 16132 Genoa, Italy.

Publikováno v: Cancers [Cancers (Basel)] 2022 Sep 13; Vol. 14 (18). Date of Electronic Publication: 2022 Sep 13.

An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA.

Autor: Conteduca V; IRCCS Istituto Romagnolo per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Brighi N; IRCCS Istituto Romagnolo per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Conteduca D; Photonics Group, Department of Physics, University of York, Heslington, UK., Bleve S; IRCCS Istituto Romagnolo per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gianni C; IRCCS Istituto Romagnolo per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Schepisi G; IRCCS Istituto Romagnolo per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Iaia ML; IRCCS Istituto Romagnolo per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gurioli G; IRCCS Istituto Romagnolo per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Lolli C; IRCCS Istituto Romagnolo per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., De Giorgi U; IRCCS Istituto Romagnolo per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.

Publikováno v: Expert review of molecular diagnostics [Expert Rev Mol Diagn] 2021 Jul; Vol. 21 (7), pp. 631-640. Date of Electronic Publication: 2021 Jun 14.